APLS

$0.00

(

+0.00%

)
Quote details

stock

Apellis Pharmaceuticals Inc

NASDAQ | APLS

24.96

USD

+$0.00

(

+0.00%

)

At Close (As of Dec 11, 2025)

$3.12B

Market Cap

68.56

P/E Ratio

0.36

EPS

$35.70

52 Week High

$16.10

52 Week Low

HEALTHCARE

Sector

APLS Chart

Recent Chart
Price Action

APLS Technicals

Tags:

APLS Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $664M
Total Revenue $781M
Cost Of Revenue $118M
Costof Goods And Services Sold $118M
Operating Income -$165M
Selling General And Administrative $418M
Research And Development $328M
Operating Expenses $829M
Investment Income Net -
Net Interest Income -$28M
Interest Income $13M
Interest Expense $40M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.8M
Income Before Tax -$197M
Income Tax Expense $1.2M
Interest And Debt Expense -
Net Income From Continuing Operations -$198M
Comprehensive Income Net Of Tax -
Ebit -$156M
Ebitda -$155M
Net Income -$198M

Revenue & Profitability

Earnings Performance

APLS Financials

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $664M
Total Revenue $781M
Cost Of Revenue $118M
Costof Goods And Services Sold $118M
Operating Income -$165M
Selling General And Administrative $418M
Research And Development $328M
Operating Expenses $829M
Investment Income Net -
Net Interest Income -$28M
Interest Income $13M
Interest Expense $40M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.8M
Income Before Tax -$197M
Income Tax Expense $1.2M
Interest And Debt Expense -
Net Income From Continuing Operations -$198M
Comprehensive Income Net Of Tax -
Ebit -$156M
Ebitda -$155M
Net Income -$198M

APLS News

APLS Profile

Apellis Pharmaceuticals Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Apellis Pharmaceuticals, Inc. is an innovative clinical-stage biopharmaceutical company located in Waltham, Massachusetts, specializing in the development of groundbreaking therapies that target the complement system for the treatment of autoimmune and inflammatory diseases. With a robust pipeline, including its flagship investigational asset, the company aims to transform treatment paradigms for patients suffering from complex conditions marked by unmet medical needs. Committed to advancing the science of complement inhibition, Apellis is poised to play a pivotal role in reshaping the biopharmaceutical landscape and delivering impactful solutions to healthcare challenges.

ATPC
+164.70%
$0.18
LPTX
+368.57%
$2.05
NVDA
-1.55%
$180.93
WOK
-11.52%
$0.16
PAVS
-9.21%
$0.03
VSME
+11.42%
$0.09
PETS
+68.36%
$2.98
RZLT
-87.20%
$1.40
YGMZ
-61.42%
$0.02
PLUG
+4.42%
$2.36
ORCL
-10.83%
$198.85
RIVN
-6.11%
$16.43
ASST
-7.82%
$0.92
VIVK
+14.55%
$0.07
URG
-8.08%
$1.25
NXDR
+9.48%
$2.77
KIND
+9.48%
$2.77
AXDX
-61.36%
$0.03
IVP
-12.52%
$0.05
ONDS
+8.34%
$9.02
IRBT
-4.58%
$5.00
INTC
-3.11%
$39.51
F
+1.64%
$13.63
MIGI
-8.95%
$6.10
TSLA
-1.01%
$446.89
KVUE
0.00%
$17.32
BTTC
+24.28%
$4.12
ADAP
-15.14%
$0.05
DNN
+2.60%
$2.76
AAL
-1.18%
$14.96
AVGO
-1.59%
$406.37
HOOD
-9.05%
$123.38
MARA
-0.67%
$11.84
NFLX
+1.48%
$94.09
TE
-4.55%
$5.87
K
-0.01%
$83.44
SOND
-23.45%
$0.12
GOOGL
-2.42%
$312.43
SOFI
-0.07%
$27.07
BMNR
-5.00%
$38.38
WBD
-0.13%
$29.49
BTG
0.00%
$4.68
RR
+12.77%
$4.68
VALE
+2.30%
$13.29
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
T
-0.36%
$24.30
RGTI
+2.90%
$26.88
BYND
-4.06%
$1.18
ADD
-25.47%
$0.05
NIO
+1.98%
$5.13
PLTR
-0.19%
$187.54
BAC
+0.88%
$54.56
SRM
+53.27%
$10.30
PFE
+0.07%
$25.80
HL
+12.56%
$19.35
ASBP
+22.50%
$0.10
PLTD
+0.15%
$6.32
AAPL
-0.26%
$278.03
GRAB
0.00%
$5.18
BITF
0.00%
$2.94
HPE
-2.85%
$24.54
RIG
-0.46%
$4.28
RKLB
+10.44%
$63.53
JBLU
-2.78%
$4.89
QBTS
+4.40%
$27.98
AMD
+0.00%
$221.43
BMNU
-10.03%
$10.22
CIFR
+2.16%
$18.88
NGD
+9.19%
$8.55
ACHR
+2.27%
$8.56
AG
+7.13%
$16.81
CDE
+9.45%
$17.48
AMZN
-0.64%
$230.28
MTSR
-0.35%
$70.50
BBD
+2.71%
$3.41
BTBT
+4.23%
$2.46
SNAP
-3.53%
$7.64
CRWV
-0.88%
$87.38
IREN
+0.04%
$43.94
NCLH
+6.80%
$20.55
ABEV
+2.04%
$2.50
FI
+2.38%
$68.16
GOOG
-2.27%
$313.70
NOK
+2.25%
$6.36
MSFT
+1.02%
$483.47
HBAN
+1.99%
$17.91
CCL
+5.93%
$27.84
PCG
-1.65%
$14.83
AFMD
-34.94%
$0.18
KO
-1.56%
$69.11
SMCI
-2.52%
$34.02
WULF
+0.44%
$15.83
LUV
+2.28%
$40.74
UBER
+1.52%
$85.44
CNQ
-1.72%
$33.14
SOUN
-1.47%
$12.03
SMR
+4.42%
$21.22
CHR
-5.72%
$0.04
CLSK
+1.99%
$14.82
ATPC
+164.70%
$0.18
LPTX
+368.57%
$2.05
NVDA
-1.55%
$180.93
WOK
-11.52%
$0.16
PAVS
-9.21%
$0.03
VSME
+11.42%
$0.09
PETS
+68.36%
$2.98
RZLT
-87.20%
$1.40
YGMZ
-61.42%
$0.02
PLUG
+4.42%
$2.36
ORCL
-10.83%
$198.85
RIVN
-6.11%
$16.43
ASST
-7.82%
$0.92
VIVK
+14.55%
$0.07
URG
-8.08%
$1.25
NXDR
+9.48%
$2.77
KIND
+9.48%
$2.77
AXDX
-61.36%
$0.03
IVP
-12.52%
$0.05
ONDS
+8.34%
$9.02
IRBT
-4.58%
$5.00
INTC
-3.11%
$39.51
F
+1.64%
$13.63
MIGI
-8.95%
$6.10
TSLA
-1.01%
$446.89
KVUE
0.00%
$17.32
BTTC
+24.28%
$4.12
ADAP
-15.14%
$0.05
DNN
+2.60%
$2.76
AAL
-1.18%
$14.96
AVGO
-1.59%
$406.37
HOOD
-9.05%
$123.38
MARA
-0.67%
$11.84
NFLX
+1.48%
$94.09
TE
-4.55%
$5.87
K
-0.01%
$83.44
SOND
-23.45%
$0.12
GOOGL
-2.42%
$312.43
SOFI
-0.07%
$27.07
BMNR
-5.00%
$38.38
WBD
-0.13%
$29.49
BTG
0.00%
$4.68
RR
+12.77%
$4.68
VALE
+2.30%
$13.29
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
T
-0.36%
$24.30
RGTI
+2.90%
$26.88
BYND
-4.06%
$1.18
ADD
-25.47%
$0.05
NIO
+1.98%
$5.13
PLTR
-0.19%
$187.54
BAC
+0.88%
$54.56
SRM
+53.27%
$10.30
PFE
+0.07%
$25.80
HL
+12.56%
$19.35
ASBP
+22.50%
$0.10
PLTD
+0.15%
$6.32
AAPL
-0.26%
$278.03
GRAB
0.00%
$5.18
BITF
0.00%
$2.94
HPE
-2.85%
$24.54
RIG
-0.46%
$4.28
RKLB
+10.44%
$63.53
JBLU
-2.78%
$4.89
QBTS
+4.40%
$27.98
AMD
+0.00%
$221.43
BMNU
-10.03%
$10.22
CIFR
+2.16%
$18.88
NGD
+9.19%
$8.55
ACHR
+2.27%
$8.56
AG
+7.13%
$16.81
CDE
+9.45%
$17.48
AMZN
-0.64%
$230.28
MTSR
-0.35%
$70.50
BBD
+2.71%
$3.41
BTBT
+4.23%
$2.46
SNAP
-3.53%
$7.64
CRWV
-0.88%
$87.38
IREN
+0.04%
$43.94
NCLH
+6.80%
$20.55
ABEV
+2.04%
$2.50
FI
+2.38%
$68.16
GOOG
-2.27%
$313.70
NOK
+2.25%
$6.36
MSFT
+1.02%
$483.47
HBAN
+1.99%
$17.91
CCL
+5.93%
$27.84
PCG
-1.65%
$14.83
AFMD
-34.94%
$0.18
KO
-1.56%
$69.11
SMCI
-2.52%
$34.02
WULF
+0.44%
$15.83
LUV
+2.28%
$40.74
UBER
+1.52%
$85.44
CNQ
-1.72%
$33.14
SOUN
-1.47%
$12.03
SMR
+4.42%
$21.22
CHR
-5.72%
$0.04
CLSK
+1.99%
$14.82

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.